| Application Procedure: Candidates for residency are
expected to have completed a primary care residency program (family
practice, internal medicine, OB/GYN or pediatrics) in the United
States. The candidate must also be licensed to practice medicine
in the United States. Applicants must complete an application
form and send this along with a letter of intent and a current
curriculum vitae. Arrangements should also be made for three letters
of reference to be sent.
All materials should be addressed to: Robert A. Saul, M.D., Greenwood Genetic Center,
101 Gregor Mendel Circle, Greenwood, SC 29646.
Application to the residency program should be completed by
January 1st for July 1st appointment. Interviews are arranged
and final decisions will be made as soon as possible. Greenwood
Genetic Center is an Equal Opportunity Employer. Women and interested
minorities are encouraged to apply.
Post-Doctoral Fellowship Programs
Clinical
Cytogenetics
The clinical cytogenetic fellowship program allows the trainee
to gain competence in performing and interpreting cytogenetic
analysis relevant to the diagnosis and management of chromosome
disorders. The trainee will also gain research experience by participating
in on-going research projects and by conducting independent research.
The cytogenetic laboratory at the Greenwood Genetic Center
processes approximately 2500 samples per year for chromosome analysis.
The sample load includes about 1500 peripheral bloods, 400 amniotic
fluids, 50 chorionic villus samples, 500 bone marrows, 350 solid tissues, and
1500 FISH analyses. The trainee will rotate through each of the cytogenetic
laboratory sections: peripheral blood/bone marrow, prenatal diagnosis
(amniotic fluid/CVS), and solid tissue.
The purpose of these laboratory rotations is to gain expertise
in culturing and analyzing each specimen type and to gain experience
in interpreting test results. Within each laboratory section,
the trainee will perform routine G-banded analysis and will perform
special staining such as C-banding, silver staining, R-banding,
and Q-banding, when indicated. The trainee will also perform fluorescence
in situ hybridization (FISH) and array CGH for the diagnosis of microdeletion
and microduplication
syndromes, the detection of aneuploidy in uncultured cells, and
the identification of marker chromosomes.
During the rotations within the cytogenetic laboratory, the
trainee will follow specimens from set-up to completion. This
experience will allow the trainee to accumulate an adequate case
load to complete the logbook required for the ABMG certification
examination.
By attending weekly clinic conference, weekly laboratory conference,
and monthly state-wide case review, the trainee will interact
with clinical geneticists, genetic counselors and others who refer
patients for cytogenetic testing. This interaction will allow
discussion of pertinent clinical features corresponding with laboratory
findings and will permit the opportunity for discussion of counseling
issues such as long term prognosis, family studies, recurrence
risks, and additional laboratory testing. In addition, the trainee
is required to participate in a core course in Advanced Human
Genetics by attending all lectures and by limited teaching responsibilities.
An individual completing the the fellowship program will possess
the skills required for certification by the ABMG, including:
- The ability to supervise and direct a diagnostic cytogenetic
laboratory.
- The understanding of the heterogeneity, variability, and
natural history of chromosome disorders.
- The capacity to diagnose and interpret a wide range of cytogenetic
problems.
- The competence to communicate results as a consultant to
other clinicians, genetic counselors, and to patients in cooperation
with a clinical staff.
Clinical
Molecular Genetics
Candidates with an M.D. or a Ph.D. degree in one of the basic
sciences may enter this program. The molecular genetics fellowship
program allows the trainee to gain competence in all molecular
analyses relevant to the diagnosis of genetic disorders at the
gene level. The DNA Diagnostic Laboratory handles blood, amniocytes
and CVS tissue samples for molecular analysis. The trainee will
gain expertise in PCR, Southern hybridization, SSCP, FISH, linkage
analysis, DNA sequencing. At completion of the program, Clinical
Molecular Fellows will possess the skills required for certification
by the ABMG, including competence in:
- The ability to supervise and direct the operations of a clinical
molecular genetics diagnostic laboratory.
- The ability to perform a variety of diagnostic assays.
- A broad knowledge of
- basic molecular biology and genetics
- the application of recombinant DNA techniques and linkage
analysis to diagnosis of genetic diseases
- the etiology, pathogenesis, clinical manifestations/management
of genetic disorders.
- The ability to appropriately interpret and communicate molecular
diagnostic laboratory results in the capacity of a consultant
to other clinicians or directly to patients in concert with other
clinicians or genetic counselors.
Clinical
Biochemical Genetics
The clinical biochemical genetics fellowship program will allow
the trainee to gain competence to perform and interpret biochemical
analyses and diagnostic techniques relevant to the diagnosis and
management of human biochemical genetic diseases, and will act
as a consultant regarding the laboratory diagnosis of a broad
range of biochemical/metabolic conditions. An individual completing
the fellowship program will possess the skills required for certification
by the ABMG including:
- The ability to supervise and direct the operations of a clinical
biochemical genetic diagnostic laboratory.
- A broad knowledge of
- basic biochemistry and biology
- the application of biochemical techniques to the diagnosis
and management of genetic biochemical/metabolic diseases
- the etiology, pathogenesis, clinical manifestations, and
management of human inherited biochemical conditions.
- The ability to appropriately interpret and communicate biochemical
laboratory results as a consultant to other clinicians, genetic
counselors, or directly to patients in cooperation with a clinical
staff.
|